Sai-Juan Chen
Overview
Explore the profile of Sai-Juan Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
200
Citations
7336
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shi Q, He Y, Yi H, Mu R, Jiang X, Fu D, et al.
Cancer Commun (Lond)
. 2023 Jul;
43(8):896-908.
PMID: 37403255
Background: The current standard of care for non-bulky diffuse large B-cell lymphoma (DLBCL) patients with an International Prognostic Index (IPI) of 0 is four cycles of rituximab plus cyclophosphamide, doxorubicin,...
12.
Feng C, Li N, Hu X, Xie Y, Huang Q, Zhang J, et al.
Genes Dis
. 2023 Jul;
10(3):735-738.
PMID: 37396509
No abstract available.
13.
Mi J, Zhao W, Jing H, Jin J, Chen S
Eur J Cancer
. 2023 May;
188:108-110.
PMID: 37229834
No abstract available.
14.
Chen Z, Hu H, Yang J, Xing D, Deng X, Zou Y, et al.
Environ Health Prev Med
. 2023 May;
28:28.
PMID: 37164757
Background: Global warming and increasing extreme weather have become a severe problem in recent years, posing a significant threat to human health worldwide. Research exploring the link between injury as...
15.
Wang W, Hu F, Zhou D, Gale R, Lai Y, Yao H, et al.
Blood Rev
. 2023 Mar;
60:101074.
PMID: 36963988
Because of successful thalassaemia prevention programmes in resource-rich countries and it's huge population China now has the greatest number of new cases of thalassaemia globally as well as more people...
16.
Chen Z, Deng X, Zou Y, He Y, Chen S, Wang Q, et al.
Arch Public Health
. 2023 Mar;
81(1):42.
PMID: 36945028
Background: Tuberculosis (TB) is a serious infectious disease that is one of the leading causes of death worldwide. This study aimed to investigate the spatial and temporal distribution patterns and...
17.
Rein A, Geron I, Kugler E, Fishman H, Gottlieb E, Abramovich I, et al.
Haematologica
. 2022 Dec;
108(9):2316-2330.
PMID: 36475518
Mono-allelic germline disruptions of the transcription factor GATA2 result in a propensity for developing myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), affecting more than 85% of carriers. How a...
18.
Cheng W, Li J, Zhu Y, Lin X, Wen L, Zhang F, et al.
Proc Natl Acad Sci U S A
. 2022 Nov;
119(49):e2211429119.
PMID: 36442087
The current classification of acute myeloid leukemia (AML) relies largely on genomic alterations. Robust identification of clinically and biologically relevant molecular subtypes from nongenomic high-throughput sequencing data remains challenging. We...
19.
Hu C, Chen B, Li Z, Yang T, Xu C, Yang R, et al.
Cell Res
. 2022 Oct;
32(12):1105-1123.
PMID: 36302855
Aberrant self-renewal of leukemia initiation cells (LICs) drives aggressive acute myeloid leukemia (AML). Here, we report that UHRF1, an epigenetic regulator that recruits DNMT1 to methylate DNA, is highly expressed...
20.
Mi J, Zhao W, Jing H, Fu W, Hu J, Chen L, et al.
J Clin Oncol
. 2022 Oct;
41(6):1275-1284.
PMID: 36269898
Purpose: CARTIFAN-1 aimed to evaluate the efficacy and safety of ciltacabtagene autoleucel (cilta-cel), a B-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy, in Chinese patients with relapsed/refractory multiple myeloma (RRMM)....